As the incidence of type 1 diabetes increases in adults, this topic is of growing importance to nephrology nurses. This session covers the incidence, pathophysiologic causes/risks for development of type 1 diabetes, and treatment options.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/16/2025.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures: There are no Planning Committee disclosures to declare.
Speaker Disclosures: There are no speaker disclosures to declare.
Commercial Support: No commercial support declared.
Accreditation Statement: The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome: After completing this learning activity, the participant will be able to discuss the incidence, pathophysiologic causes/risks for the development of Type 1 diabetes, plus new diagnostic testing and treatments for both children and adults with Type 1 diabetes.
PhD, APRN, ACNP-BC,
Clinical Associate Professor; Student Success Faculty,
University of Texas at Arlington